María I. Albarrán

465 total citations
14 papers, 304 citations indexed

About

María I. Albarrán is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, María I. Albarrán has authored 14 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Organic Chemistry and 4 papers in Genetics. Recurrent topics in María I. Albarrán's work include Quinazolinone synthesis and applications (7 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Cancer Mechanisms and Therapy (4 papers). María I. Albarrán is often cited by papers focused on Quinazolinone synthesis and applications (7 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Cancer Mechanisms and Therapy (4 papers). María I. Albarrán collaborates with scholars based in Spain, United States and Belgium. María I. Albarrán's co-authors include Joaquı́n Pastor, Julen Oyarzábal, Antonio Cebriá, James R. Bischoff, Obdulia Rabal, Jesús Fominaya, Carmen Blanco‐Aparicio, Rosa M. Álvarez, Sonia Martı́nez and Ana Isabel Hernández and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

María I. Albarrán

14 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
María I. Albarrán Spain	11	199	122	61	40	35	14	304
Gulnaz Khafizova United States	6	238 1.2×	122 1.0×	32 0.5×	51 1.3×	7 0.2×	6	334
Zuohe Song United States	10	298 1.5×	68 0.6×	25 0.4×	49 1.2×	28 0.8×	11	394
Catherine Bardelle United Kingdom	12	237 1.2×	47 0.4×	11 0.2×	66 1.6×	39 1.1×	20	395
Jee Sun Yang South Korea	13	240 1.2×	153 1.3×	23 0.4×	78 1.9×	14 0.4×	17	419
Olga Abramczyk United States	13	400 2.0×	44 0.4×	26 0.4×	51 1.3×	43 1.2×	14	536
Lijiao Wang China	10	157 0.8×	97 0.8×	22 0.4×	67 1.7×	16 0.5×	24	334
Amit Shraga Israel	7	354 1.8×	59 0.5×	15 0.2×	67 1.7×	19 0.5×	7	387
Saskia Hulscher Netherlands	8	215 1.1×	41 0.3×	15 0.2×	103 2.6×	21 0.6×	10	339
Da-Qiang Li China	11	334 1.7×	44 0.4×	45 0.7×	139 3.5×	41 1.2×	19	425
Pondy Murugappan Ramanujulu Singapore	10	279 1.4×	103 0.8×	17 0.3×	112 2.8×	26 0.7×	10	394

Countries citing papers authored by María I. Albarrán

Since Specialization

Citations

This map shows the geographic impact of María I. Albarrán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María I. Albarrán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María I. Albarrán more than expected).

Fields of papers citing papers by María I. Albarrán

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María I. Albarrán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María I. Albarrán. The network helps show where María I. Albarrán may publish in the future.

Co-authorship network of co-authors of María I. Albarrán

This figure shows the co-authorship network connecting the top 25 collaborators of María I. Albarrán. A scholar is included among the top collaborators of María I. Albarrán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María I. Albarrán. María I. Albarrán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Martı́nez, Sonia, Rosa M. Álvarez, J. I. Martı́n, et al.. (2021). Macrocyclization as a Source of Desired Polypharmacology. Discovery of Triple PI3K/mTOR/PIM Inhibitors. ACS Medicinal Chemistry Letters. 12(11). 1794–1801. 10 indexed citations

Álvarez, Rosa M., Ana Belén Garcı́a, J. I. Martı́n, et al.. (2020). Omipalisib inspired macrocycles as dual PI3K/mTOR inhibitors. European Journal of Medicinal Chemistry. 211. 113109–113109. 18 indexed citations

Martı́nez, Sonia, Ana Belén Garcı́a, María I. Albarrán, et al.. (2020). Pyrido[2,3-b][1,5]benzoxazepin-5(6H)-one derivatives as CDK8 inhibitors. European Journal of Medicinal Chemistry. 201. 112443–112443. 11 indexed citations

Cash, Timothy P., Sonia Alcalá, Jennifer García, et al.. (2020). Induction of Lysosome Membrane Permeabilization as a Therapeutic Strategy to Target Pancreatic Cancer Stem Cells. Cancers. 12(7). 1790–1790. 10 indexed citations

Martı́nez, Sonia, Ana Isabel Hernández, Ana Belén Garcı́a, et al.. (2019). Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors. European Journal of Medicinal Chemistry. 168. 87–109. 26 indexed citations

Martı́nez, Sonia, Ana Isabel Hernández, Rosa M. Álvarez, et al.. (2017). Identification of novel PI3K inhibitors through a scaffold hopping strategy. Bioorganic & Medicinal Chemistry Letters. 27(21). 4794–4799. 6 indexed citations

Martı́nez, Sonia, Ana Isabel Hernández, Rosa M. Álvarez, et al.. (2017). Generation of tricyclic imidazo[1,2-a]pyrazines as novel PI3K inhibitors by application of a conformational restriction strategy. Bioorganic & Medicinal Chemistry Letters. 27(11). 2536–2543. 7 indexed citations

Granda, Teresa G., David Cebrián, Sonia Martı́nez, et al.. (2012). Biological characterization of ETP-46321 a selective and efficacious inhibitor of phosphoinositide-3-kinases. Investigational New Drugs. 31(1). 66–76. 15 indexed citations

Pastor, Joaquı́n, Julen Oyarzábal, Rosa M. Álvarez, et al.. (2012). Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(4). 1591–1597. 35 indexed citations

10.

Albarrán, María I., Rosa M. Álvarez, Obdulia Rabal, et al.. (2012). Fragment-Hopping-Based Discovery of a Novel Chemical Series of Proto-Oncogene PIM-1 Kinase Inhibitors. PLoS ONE. 7(10). e45964–e45964. 19 indexed citations

11.

Martı́nez, Sonia, Ana Isabel Hernández, Rosa M. Álvarez, et al.. (2012). Imidazo[1,2-a]pyrazines as novel PI3K inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(5). 1874–1878. 26 indexed citations

12.

Oyarzábal, Julen, Natasha Zarich, María I. Albarrán, et al.. (2010). Discovery of Mitogen-Activated Protein Kinase-Interacting Kinase 1 Inhibitors by a Comprehensive Fragment-Oriented Virtual Screening Approach. Journal of Medicinal Chemistry. 53(18). 6618–6628. 28 indexed citations

13.

Link, Wolfgang, Julen Oyarzábal, María I. Albarrán, et al.. (2009). Chemical Interrogation of FOXO3a Nuclear Translocation Identifies Potent and Selective Inhibitors of Phosphoinositide 3-Kinases. Journal of Biological Chemistry. 284(41). 28392–28400. 69 indexed citations

14.

Vázquez, María J., María I. Albarrán, Alfonso Espada, et al.. (2005). A New Destruxin as Inhibitor of Vacuolar-Type H⁺-ATPase ofSaccharomyces cerevisiae. Chemistry & Biodiversity. 2(1). 123–130. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact